THE D-1 DOPAMINE RECEPTOR PARTIAL AGONIST, CY 208-243, EXHIBITS ANTIPARKINSONIAN ACTIVITY IN THE MPTP-TREATED MARMOSET

被引：59
|
作者：
TEMLETT, JA
PIANG, NC
OERTEL, WH
JENNER, P
MARSDEN, CD
机构：
[1] UNIV LONDON,DEPT NEUROL,MRC,MOVEMENT DISORDERS RES GRP,LONDON SE5 8AF,ENGLAND
[2] INST PSYCHIAT,PARKINSONS DIS SOC RES CTR,LONDON SE5,ENGLAND
[3] UNIV LONDON KINGS COLL HOSP,SCH MED,LONDON SE5 8RX,ENGLAND
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 1988年 / 156卷 / 02期
关键词：
D O I：
10.1016/0014-2999(88)90322-6
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：197 / 206
页数：10
相关论文
共 50 条
  • [31] Aplindore (DAB-452) exhibits high affinity dopamine D2 receptor partial agonist activity
    Pausch, M
    Heinrich, JN
    Lai, M
    Carroll, K
    Homby, G
    Popiolek, M
    Jiang, L
    Stack, G
    Marquis, KL
    Andree, TH
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 308 - 308
  • [32] Effect of 5-HT1B/D receptor agonist and antagonist administration on motor function in haloperidol and MPTP-treated common marmosets
    Jackson, MJ
    Al-Barghouthy, G
    Pearce, RKB
    Smith, L
    Hagan, JJ
    Jenner, P
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2004, 79 (03) : 391 - 400
  • [33] Combined use of the adenosine A2A antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys
    Kanda, T
    Jackson, MJ
    Smith, LA
    Pearce, RKB
    Nakamura, J
    Kase, H
    Kuwana, Y
    Jenner, P
    EXPERIMENTAL NEUROLOGY, 2000, 162 (02) : 321 - 327
  • [34] SELECTIVE DOPAMINE D-1-RECEPTOR AGONISTS, SK-AND-F-38393 AND CY-208-243 REDUCE SUCROSE SHAM-FEEDING IN THE RAT
    COOPER, SJ
    FRANCIS, J
    BARBER, DJ
    NEUROPHARMACOLOGY, 1993, 32 (01) : 101 - 102
  • [35] BLOOD-PRESSURE AND PLASMA-CATECHOLAMINES IN NEVER-TREATED PARKINSONIAN-PATIENTS - EFFECT OF A SELECTIVE D1 AGONIST (CY-208-243)
    DURRIEU, G
    SENARD, JM
    RASCOL, O
    TRAN, MA
    LATASTE, X
    RASCOL, A
    MONTASTRUC, JL
    NEUROLOGY, 1990, 40 (04) : 707 - 709
  • [36] THE D-1 DOPAMINE AGONIST SKF38393 MAY NOT HELP THE EFFECTS OF THE D-2 DOPAMINE AGONIST LY171555 ON PARKINSONISM INDUCED BY 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) IN THE COMMON MARMOSET
    NOMOTO, M
    JENNER, P
    MARSDEN, CD
    JAPANESE JOURNAL OF PHARMACOLOGY, 1987, 43 : P83 - P83
  • [37] D-1 dopamine receptor stimulation inhibits firing activity of midbrain dopamine neurons in reserpine treated rats: An effect eliminated after hemitransection of diencephalon
    Sun, BC
    Chouvet, G
    Jin, GZ
    SYNAPSE, 1996, 24 (01) : 29 - 38
  • [38] Switching from levodopa to the long-acting dopamine D2/D3 agonist Piribedil reduces the expression of dyskinesia while maintaining effective motor activity in MPTP-treated primates
    Smith, Lance A.
    Jackson, Michael J.
    Johnston, Louisa
    Kuoppamaki, Mikko
    Rose, Sarah
    Al-Bargbouthy, Ghassan
    Del Signore, Susanna
    Jenner, Peter
    CLINICAL NEUROPHARMACOLOGY, 2006, 29 (03) : 112 - 125
  • [39] WHY DOES CLOZAPINE STIMULATE THE MOTOR-ACTIVITY OF RESERPINE-PRETREATED RATS WHEN COMBINED WITH A DOPAMINE D-1 RECEPTOR AGONIST
    JACKSON, DM
    MOHELL, N
    BENGTSSON, A
    MALMBERG, A
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 282 (1-3) : 137 - 144
  • [40] STRUCTURE-ACTIVITY-RELATIONSHIPS IN THE TRANS-HEXAHYDROINDOLO[4,3-AB]PHENANTHRIDINE (BENZERGOLINE) SERIES .2. RESOLUTION, ABSOLUTE-CONFIGURATION, AND DOPAMINERGIC ACTIVITY OF THE SELECTIVE D(1) AGONIST CY-208-243 AND ITS IMPLICATION FOR AN EXTENDED ROTAMER-BASED DOPAMINE RECEPTOR MODEL
    SEILER, MP
    FLOERSHEIM, P
    MARKSTEIN, R
    WIDMER, A
    JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (08) : 977 - 984
12345